-
1 Comment
PZ Cormay S.A. is currently in a long term downtrend where the price is trading 3.8% below its 200 day moving average.
PZ Cormay S.A.'s total revenue sank by 24.2% to $14M since the same quarter in the previous year.
Its net income has increased by 22.4% to $-2M since the same quarter in the previous year.
Finally, its free cash flow fell by 18.9% to $-5M since the same quarter in the previous year.
Based on the above factors, PZ Cormay S.A. gets an overall score of 1/5.
| Industry | Scientific & Technical Instruments |
|---|---|
| Sector | Technology |
| ISIN | PLCMRAY00029 |
| CurrencyCode | PLN |
| Exchange | WAR |
| Dividend Yield | 0.0% |
|---|---|
| Beta | 0.79 |
| Target Price | None |
| PE Ratio | None |
| Market Cap | 64M |
PZ Cormay S.A. develops, manufactures, and sells diagnostic reagents in Poland. It offers testing products for clinical chemistry, hematology, veterinary, urinalysis, and parasitology, as well as rapid test products. The company serves small and medium size clinical laboratories, clinics, and hospitals. It distributes its products to approximately 120 countries. PZ Cormay S.A. was founded in 1985 and is headquartered in Lomianki, Poland.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for CRM.WAR using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
